Stock Price

The plumbing and HVAC giant is delisting from London, a move that solidifies its North American focus and sends a clear signal about global capital flows.

Solidion Technology unveils its AI-assisted BEEP battery, promising a lighter, cheaper, and more powerful solid-state solution for eVTOLs and data centers.

With fresh capital, SuperQ Quantum aims to move from niche deep tech to mainstream tool. But can its hybrid strategy and global push justify the investment?

Great Estate Blockchain divests its main revenue source after a flawed deal structure implodes, leaving the penny-stock firm seeking a new identity.

Light AI's smartphone diagnostic tool enters a crucial New Zealand study, but can its innovative tech overcome financial pressures and regulatory hurdles?

With the hire of LongHorn Steakhouse veteran Monika Saxena, BJ's is betting that a data-driven focus on brand and guest experience is the key ingredient.

As AeroVironment preps its year-end report, all eyes are on whether its battlefield-proven technology can meet soaring expectations amid a global arms race.

Phil McCabe, the man who built modern Naples, just made a $20M+ purchase at the new Four Seasons. It’s more than a home—it’s a signal about the future of luxury capital.

Facing sinking sales and credit downgrades, the appliance giant is swapping cheap, short-term debt for costly long-term security. A deep dive into a bold gambit.

PAVS's stock soars over 100% despite a dilutive $10M offering. A look into how a potential activewear acquisition is rewriting the narrative for this company.

A silent productivity drain is costing businesses dearly. Over half the workforce aged 40-60 is managing elder care, and the financial and career toll is immense.

The electric boat innovator executes another reverse stock split to stay on Nasdaq, but a history of similar moves raises questions about its financial health.

New clinical trial results for XWRAP® show a significant leap in healing diabetic ulcers, positioning Applied Biologics as a formidable player in a challenging field.

The Defiance 2X Space ETF was halted amidst the SpaceX IPO frenzy, revealing the extreme volatility and complex risks of new leveraged financial products.

With projections of $22.7M from four new supplements, Cosmos Health is betting big on the US. But can its 'science-driven' platform deliver in a crowded market?

With CEO Reedy's sudden retirement, aerospace innovator Butler National enters a critical transition. We explore his legacy and what's next for the tech firm.

With a landmark therapy for Sanfilippo Syndrome nearing the FDA, Spruce adds veteran marketing and finance chiefs. A look at the talent behind the transition.

With over 4.6% of all ETH, Bitmine is not just mining crypto; it's engineering a new kind of financial institution. Is its high-stakes strategy genius or hubris?

Beyond a steady distribution, Chartwell's latest update signals a bold repositioning strategy. What does it mean for investors and the market?

Tiziana Life Sciences’ chairman just increased his massive stake. We analyze if this is a vote of confidence in its novel MS drug or a risky bet on a fragile biotech.